Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05442723
Other study ID # AssiutMed
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 25, 2022
Est. completion date March 1, 2023

Study information

Verified date June 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Diseased left Anterior descending coronary artery (LAD) is one of the most challenging conditions in Bypass surgery. we investigate whether on-pump coronary artery bypass grafting (CABG) is more beneficial in those critical patients or off-pump surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date March 1, 2023
Est. primary completion date February 24, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years and older
Eligibility Inclusion Criteria: - any patient with diffuse LAD disease indicated for open heart surgery Exclusion Criteria: - no concomitant valve disease - any patient can be treated by medical treatment or PCI

Study Design


Intervention

Procedure:
On-Pump CABG
coronary artery grafting by using cardiopulmonary bypass machine
Off-Pump CABG
coronary artery grafting by beating heart technique

Locations

Country Name City State
Egypt Assiut university heart hospital Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary mortality follow up post-operative track of the patient for any noticed mortality rate 30 days post operative
Primary Morbidity follow up post-operative track of the patient for any noticed complications 60 days post operative
See also
  Status Clinical Trial Phase
Completed NCT03005028 - Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study N/A